Clinical Trials in Arizona

Showing 14661-14680 of 16,770 trials

Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

NCT00291057

In a previous phase II study, the safety and efficacy of a novel formulation of malathion 0.5% was evaluated in patients 2 years of age and older. Based on the results of that study, this formulation is currently in a phase III study for that population. The current study will use blood markers and clinical evaluations to determine the safety and tolerability of this formulation when used in children 6-24 months of age.

Lice Infestations

Sun Pharmaceutical Industries, Inc.30 participantsStarted Feb 2006

Scottsdale, Arizona, United States • St. Petersburg, Florida, United States • West Palm Beach, Florida, United States +2 more locations

COMPLETEDPhase 442 miles

Tiotropium In Exercise

NCT00525512

The objective of this study is to evaluate the effects on exercise duration of 96 weeks treatment with 18 mcg tiotropium (Spiriva HandiHaler) daily as compared to placebo, in patients with COPD.

Pulmonary Disease, Chronic ObstructiveExercise

Boehringer Ingelheim519 participantsStarted Aug 2007

Jasper, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +59 more locations

Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice

Tiotropium In Exercise

Find Trials by Condition in Arizona

A Therapeutic Equivalence Study of Two Metronidazole 1%Topical Gel Treatments for Patients With Rosacea

Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

GS-5885, GS-9451, Tegobuvir and Ribovirin in Treatment-Experienced Subjects With Chronic Genotype 1a Or 1b Hepatitis C Virus (HCV) Infection

Eflornithine in Treating Patients With Bladder Cancer

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

Vaccine Therapy in Treating Patients With Malignant Melanoma

Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Postmenopausal Women

Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder

Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer

Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery

GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma

Chemotherapy and Photodynamic Therapy in Treating Patients With Cutaneous T-Cell Lymphoma

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

Effective Communication for Preventing and Responding to Oncology Adverse Events